Pancreatitis Trial, Recruiting NCT07015580 Sponsor: Ruijin Hospital Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT07015580
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing and able to sign and date a consent form agreeing to take part and provide the required samples

Who may not be able to join:

  • You have previously had surgery on your digestive system (such as your stomach or intestines)
  • You are currently pregnant or breastfeeding
  • You have an infectious disease, cancer, or another digestive condition (such as inflammatory bowel disease, irritable bowel syndrome, acid reflux, or other stomach or abdominal problems)
  • You have taken antibiotics or immune-suppressing medications in the 30 days before your sample would be collected
  • You take probiotic supplements (such as certain yogurts, capsules, or drinks containing live bacteria) on a daily basis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
18 February 2025
Est. completion
28 February 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

characteristic of oral microbiota in patients with chronic pancreatitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov